» Articles » PMID: 11278459

Granzyme B-mediated Apoptosis Proceeds Predominantly Through a Bcl-2-inhibitable Mitochondrial Pathway

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Mar 30
PMID 11278459
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Cytotoxic T lymphocytes kill virus-infected and tumor cell targets through the concerted action of proteins contained in cytolytic granules, primarily granzyme B and perforin. Granzyme B, a serine proteinase with substrate specificity similar to the caspase family of apoptotic cysteine proteinases, is capable of cleaving and activating a number of death proteins in target cells. Despite the ability to engage the death pathway at multiple entry points, the preferred mechanism for rapid induction of apoptosis by granzyme B has yet to be clearly established. Here we use time lapse confocal microscopy to demonstrate that mitochondrial cytochrome c release is the primary mode of granzyme B-induced apoptosis and that Bcl-2 is a potent inhibitor of this pivotal event. Caspase activation is not required for cytochrome c release, an activity that correlates with cleavage and activation of Bid, which we have found to be cleaved more readily by granzyme B than either caspase-3 or caspase-8. Bcl-2 blocks the rapid destruction of targets by granzyme B by blocking mitochondrial involvement in the process.

Citing Articles

BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic Mechanism.

Yee C, Saxena K, Ryu E, Hung S, Singh S, Zhang Q Res Sq. 2024; .

PMID: 39711535 PMC: 11661303. DOI: 10.21203/rs.3.rs-5307127/v1.


Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets.

Qian S, Long Y, Tan G, Li X, Xiang B, Tao Y MedComm (2020). 2024; 5(12):e70024.

PMID: 39619229 PMC: 11604731. DOI: 10.1002/mco2.70024.


Developing innovative strategies of tumor‑infiltrating lymphocyte therapy for tumor treatment.

Yu Z, Shi J, Fang Y, Zhao Y, Xu A, Li N Oncol Rep. 2024; 51(6).

PMID: 38666543 PMC: 11082634. DOI: 10.3892/or.2024.8744.


Beneficial effects of alpha-1 antitrypsin therapy in a mouse model of colitis-associated colon cancer.

Al-Omari M, Al-Omari T, Batainah N, Al-Qauod K, Olejnicka B, Janciauskiene S BMC Cancer. 2023; 23(1):722.

PMID: 37532996 PMC: 10394932. DOI: 10.1186/s12885-023-11195-5.


Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review.

Ismail N, Mussa A, Al-Khreisat M, Yusoff S, Husin A, Johan M Diagnostics (Basel). 2023; 13(14).

PMID: 37510072 PMC: 10378430. DOI: 10.3390/diagnostics13142328.